Anti-ZNF703 antibody [CL0654] (ab188031)
Key features and details
- Mouse monoclonal [CL0654] to ZNF703
- Suitable for: WB, IHC-P
- Reacts with: Human
- Isotype: IgG1
Overview
-
Product name
Anti-ZNF703 antibody [CL0654]
See all ZNF703 primary antibodies -
Description
Mouse monoclonal [CL0654] to ZNF703 -
Host species
Mouse -
Tested applications
Suitable for: WB, IHC-Pmore details -
Species reactivity
Reacts with: Human
Predicted to work with: Mouse, Rat -
Immunogen
Recombinant fragment corresponding to Human ZNF703 aa 150-250.
Database link: Q9H7S9 -
Positive control
- Human breast carcinoma, colorectal adenocarcinoma, stomach, small intestine, rectum, placenta and liver tissues.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing the problem with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation.
One factor contributing to the crisis is the use of antibodies that are not suitable. This can lead to misleading results and the use of incorrect data informing project assumptions and direction. To help address this challenge, we have introduced an application and species grid on our primary antibody datasheets to make it easy to simplify identification of the right antibody for your needs.
Learn more here.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 40% Glycerol (glycerin, glycerine), 59% PBS -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Monoclonal -
Clone number
CL0654 -
Isotype
IgG1 -
Research areas
Images
-
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human colorectal carcinoma tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human stomach (ventricle cancer) tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human small intestine tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human rectum tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human placenta tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
Immunohistochemical analysis of paraffin-embedded Human liver tissue, labeling ZNF703 using ab188031 at a 1/50 dilution.
-
All lanes : Anti-ZNF703 antibody [CL0654] (ab188031) at 1/500 dilution
Lane 1 : Negative control (vector only transfected HEK293T cell lysate)
Lane 2 : ZNF703 over-expression lysate (co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in HEK293 cells)
Predicted band size: 58 kDa